LianBio Sponsored ADR (LIAN) has released an update.
LianBio is winding down its operations, including selling its pipeline assets, delisting its shares from Nasdaq, and reducing its workforce. The company plans to complete most wind-down activities by the end of 2024 and has announced a special cash dividend of $4.80 per share, totaling around $528 million. An estimated $17.2 million in costs, mostly for employee severance, is expected, with the complete dissolution of the company projected for the first half of 2027. Trading of shares may continue on over-the-counter markets post-delisting.
For further insights into LIAN stock, check out TipRanks’ Stock Analysis page.
